Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focus |
immunology
oncology drug discovery |
| gptkbp:foundedBy |
gptkb:Gary_D._Glick
|
| gptkbp:foundedIn |
2021
|
| gptkbp:fundedBy |
$218 million
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Odyssey Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:leader |
gptkb:Gary_D._Glick
|
| gptkbp:leaderTitle |
CEO
|
| gptkbp:therapeuticArea |
gptkb:cancer
autoimmune diseases |
| gptkbp:website |
https://www.odysseytx.com/
|
| gptkbp:bfsParent |
gptkb:Rahko
|
| gptkbp:bfsLayer |
8
|